PLAY PODCASTS
Why AI and Biotech are BFFs
Episode 68

Why AI and Biotech are BFFs

The convergence of Artificial Intelligence (AI) and biotechnology has emerged as one of the most exciting and transformative areas of science. Researchers are developing new tools and technology that could bring about breakthroughs to revolutionize the fields of medicine and health care. In this episode, we talk with scientists who are using AI to unlock new possibilities in the search for novel drugs, cures, and treatments.

I AM BIO · Bertrand Adanve Founder & CEO Genetic Leap, Sree Kant Founder & CEO BAKX Therapeutics, Nick Nystrom Chief Technology Officer Peptilogics, Maria Cho CEO Triplebar

March 14, 202321m 49s

Audio is streamed directly from the publisher (chtbl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

The convergence of Artificial Intelligence (AI) and biotechnology has emerged as one of the most exciting and transformative areas of science. Researchers are developing new tools and technology that could bring about breakthroughs to revolutionize the fields of medicine and health care.  In this episode, we talk with scientists who are using AI to unlock new possibilities in the search for novel drugs, cures, and treatments.

Topics

undruggable diseasesreal world dataproteinsbertrand adanvedata setstherapeuticshealthventure capitalistsrnabiotechnologycanceralzheimer’sevolutionary designconvergencealgorithmsevolutiondrug targetspeptidesgenetic leapantibioticsbakx therapeuticspeptilogics; maria chohuman genome sequencing projectrnairare diseaseslabamrimmune systemdrug developmentpharmaaiinvestorsnovel drugsmachine learningbiologypathogensinnovationnick nystromclinical trialscovid 19triplebargeneticssmall moleculesmedicinedrug discoveryemerging diseasesmoleculeslouis pasteursree kantgenomicsgerm theorywhofdacomputational drug discovery systemsantimicrobialsartificial intelligencechatgpt